Intrexon reported $1.58M in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Agenus AGEN:US USD 308K 1.72M
Amgen AMGN:US USD 1.59B 78M
Anika Therapeutics ANIK:US USD 17.48M 2.69M
AstraZeneca AZN:LN USD 2.12B 214M
Bristol Myers Squibb BMY:US USD 2.35B 324M
Gilead Sciences GILD:US USD 1.4B 47M
GlaxoSmithKline GSK:LN GBP 2.39B 250M
Heron Therapeutics HRTX:US USD 14.72M 1.46M
Intrexon XON:US USD 1.58M 234K
Karyopharm Therapeutics KPTI:US USD 980K 41K
Ligand Pharmaceuticals LGND:US USD 14.15M 1.79M
MacroGenics MGNX:US USD 3.14M 741K
Mannkind MNKD:US USD 17.46M 4.54M
Merk MRK:US USD 3.43B 715M
Novartis NOVN:VX USD 3.66B 92M
Peregrine Pharmaceuticals PPHM:US USD 27.58M 3.33M
Rigel Pharmaceuticals RIGL:US USD 250K 786K
Thermo Fisher Scientific TMO:US USD 6.25B 125M
Veracyte VCYT:US USD 26.01M 978K
YTE INCY:US USD 49.28M 4.05M